Nexeon MedSystems, Inc. is a medical device company, which focuses on the development, manufacturing, and commercialization of neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. The company is focused on providing neurostimulation products designed to improve the quality of life of patients suffering from debilitating neurological diseases. Its primary purposes are to develop and commercialize its neurostimulation technology platform for the treatment of various disorders via electrical stimulation of tissues associated with the nervous system. Its operations include operations of its subsidiaries, which include Nexeon MedSystems Europe, SARL (Nexeon Europe), Nexeon MedSystems Puerto Rico Operating Company Corporation (NXPROC), NMB (which owns and operates Medi-Line), SA, and Pulsus Medical, LLC (Pulsus). Nexeon Europe is the holding company for NXPROC and NMB. NXPROC is focused on advanced computational biology and deep learning utilization associated with the Internet of Medical Things technology. Pulsus conducts research and development related to cardiovascular disease technology.